Northwire Canada EditionSaturday, July 25, 2026
Northwire
B 0.150 +0.0% IFOS 2.28 −2.6% IMM 0.060 +0.0% ROCK 3.38 −1.7% NVX 0.250 −7.4% HAR 0.050 +0.0% YGT 0.175 +0.0% GEN 0.070 −nan% CRB 0.040 +14.3% MSA 7.07 +2.2% AEM 204.81 +0.7% OPW 0.105 +5.0% GRL 0.275 −1.8% AIS 0.150 +0.0% CUU 0.580 −1.7% SOMA 0.720 +5.9% B 0.150 +0.0% IFOS 2.28 −2.6% IMM 0.060 +0.0% ROCK 3.38 −1.7% NVX 0.250 −7.4% HAR 0.050 +0.0% YGT 0.175 +0.0% GEN 0.070 −nan% CRB 0.040 +14.3% MSA 7.07 +2.2% AEM 204.81 +0.7% OPW 0.105 +5.0% GRL 0.275 −1.8% AIS 0.150 +0.0% CUU 0.580 −1.7% SOMA 0.720 +5.9%
Financings

HPQ Silicon Closed over $1.0 Million Non-Brokered Private Placement

HPQ · Price

Executive Summary

  • HPQ Silicon Inc. closed a non‑brokered private placement of 6,170,442 common shares at $0.1625 per share, generating gross proceeds of $1,002,696.83.
  • The financing includes issuance of 333,303 warrants to CI Investment Services Inc., each exercisable at $0.18 for a 48‑month term.
  • Net proceeds will be used to advance commercialization of the company’s three core technology pillars: Fumed Silica Reactor (FSR), HPQ ENDURA+™ battery cells, and METAGENE™ green hydrogen platform.

Key Details

  • Placement Size & Pricing: 6,170,442 common shares @ $0.1625 per share → $1,002,696.83 gross proceeds.
  • Statutory Hold Period: All securities subject to a four‑month‑and‑one‑day hold period from the closing date.
  • Warrant Issuance: 333,303 warrants issued to CI Investment Services Inc.; each warrant allows purchase of one common share at an exercise price of $0.18 for 48 months, also subject to the same hold period.
  • Use of Proceeds:
  • Fumed Silica Reactor (FSR): Scale‑up and revenue generation activities.
  • HPQ ENDURA+™: Commercialization of silicon‑based anode material program supported by NRCan.
  • METAGENE™: Continued development and commercialization of autonomous green hydrogen production platform.
  • Management Participation:
  • Bernard Tourillon (Chairman, President, CEO & Director) subscribed for 615,384 common shares ($99,999.90).
  • Post‑placement, Tourillon beneficially owns/controls 22,796,794 common shares (~5.29% of outstanding shares).
  • Related‑Party Transaction: Qualified as a related‑party transaction under MI 61‑101 and TSX Venture Exchange Policy 5.9; exempt from formal valuation/minority shareholder approval because insider participation < 25% of market cap.
  • Board Approval: The Board approved the private placement, including the insider participation.
  • Closing Conditions: Placement remains subject to final acceptance by the TSX Venture Exchange.

Notable Quotes

“My $100,000 investment reflects my conviction in the Company’s ability to deliver on its near‑term execution priorities and my continued confidence in HPQ’s strategy and long‑term value creation,” – Bernard Tourillon, Chairman, President & CEO.


Materiality Assessment: Material – Positive (the financing provides over $1 M of capital to fund key commercialization initiatives and includes a notable insider investment).

Read the original news release →

More from HPQ Silicon Inc.